Roy D. Baynes
CIK 1680739 · Chief Medical Officer · last filed 2026-05-21
Roy D. Baynes is a Chief Medical Officer who has filed 57 SEC Form 4 insider transactions across 7 companies since 2016. The most recent filing, for TVTX, was dated May 21, 2026. Across all open-market trades the lifetime net is −$11.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.54M
7
57
-$11.18M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TVTX | Director | 41,500 | $52.04 | $2.16M | -$2.86M | 12 | 2026-05-21 |
| NRIX | Director | — | $16.95 | — | $0 | 3 | 2026-05-15 |
| NTRA | Director | 18,512 | $212.07 | $3.93M | -$8.32M | 30 | 2026-04-28 |
| EIKN | Chief Medical Officer | — | $8.75 | — | $0 | 1 | 2026-03-04 |
| AARD | Director | — | $3.90 | — | $0 | 1 | 2025-06-13 |
| ATRA | Director | 43,500 | $10.41 | $452.8K | $0 | 5 | 2022-06-27 |
| Travere Therapeutics, Inc. (RTRX) Delisted | Director | 14,000 | — | — | $0 | 5 | 2020-05-19 |
Recent Filings
57 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-21 | TVTX | Grant (A) | +4,000 | $0 | EDGAR |
| 2026-05-15 | NRIX | Grant (A) | — | $0 | EDGAR |
| 2026-05-06 | TVTX | Mixed | — | -$127.7K | EDGAR |
| 2026-05-04 | TVTX | Mixed | — | -$364.6K | EDGAR |
| 2026-04-28 | NTRA | Grant (A) | +83 | $0 | EDGAR |
| 2026-04-16 | TVTX | Mixed | — | -$775.8K | EDGAR |
| 2026-04-07 | TVTX | Mixed | — | -$64.8K | EDGAR |
| 2026-03-04 | EIKN | Grant (A) | — | $0 | EDGAR |
| 2026-02-03 | NTRA | Grant (A) | +70 | $0 | EDGAR |
| 2025-11-21 | NTRA | Mixed | — | -$2.28M | EDGAR |